Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions

US6956043B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Patrice Guitard · Hégenheim, FR
• Barbara Haeberlin · Riehen, CH
• Rainer Link · Heidelberg, DE
• Friedrich Richter · Schönbühl, CH

Key dates

• Filing date: Jun 4, 2003
• Grant date: Oct 18, 2005
• Expiry date: Jun 4, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P39/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.